Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
about
Targeting the CCL2-CCR2 signaling axis in cancer metastasisCelastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancerFarmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancerStimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinomaMonocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinomaDefective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.Kif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in crosstalking with OSCCExpanded network of inflammatory markers of atherogenesis: where are we now?Anti-Inflammatory Agents for Cancer Therapy.Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 productionBone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesPhase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.Chemokines in tumor angiogenesis and metastasisActivation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylationAssociation between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.A high-fat diet containing lard accelerates prostate cancer progression and reduces survival rate in mice: possible contribution of adipose tissue-derived cytokinesMonocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKTCCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration.Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB ActivityRole of chemokines in tumor growth.Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).Current and emerging therapies for bone metastatic castration-resistant prostate cancer.Clinical utilization of chemokines to combat cancer: the double-edged sword.N-methyl-N-nitro-N'-nitrosoguanidine induces the expression of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration.Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1BUpregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition.An array of possibilities in cancer research using cytokine antibody arrays.Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clusteringM-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivoChemokines and chemokine receptors as promoters of prostate cancer growth and progression.Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivoEvaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer?Role of eotaxin-1 signaling in ovarian cancerAutocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.
P2860
Q26765184-5DC187B4-8268-4A96-A339-7398D1D632F5Q28487695-98B9469D-EE88-4E42-9784-6B8C25E97774Q28649395-DB5CFD71-5EDB-454E-A610-1A328B1A566BQ33317415-C4D5DFC5-8CCF-48E0-A0D4-AA961FDAA1C2Q33618672-72E35E0E-B466-47B7-A671-5EC378DD849FQ33622444-11ECB7B3-944D-49CD-828C-D3B4864AAB31Q33714927-AB52C180-020F-4995-9494-D57018BB4633Q33738532-1F0A47C4-F3B0-4C94-9C6F-D6832F07977EQ33744129-6B5D53C7-5560-4208-907E-22D1E19209CCQ33803085-7AE59F78-A3F7-46A3-B465-24DD61374545Q33986185-3A18B927-E00B-4AE6-B347-C9470A3F642CQ34132305-732D4614-B240-4E0A-917F-53B48A84B689Q34295041-77AE4FA3-9ED0-4279-A51A-313ED27F2DACQ34415685-1E069442-6CF8-4AAC-BD19-A5A0AE9CE077Q34540743-C21EA7AD-F55B-4B8A-9F86-DF2CEC0FEDA6Q34562572-F9AB1099-64FE-44AA-8C63-6C9F6DC723B9Q34585256-6228A1AC-ABA5-4B96-84B3-AE24D01AB7F9Q35075456-6ECDE5B1-FEFF-489D-A28A-034FEE89612BQ35585932-3A745A10-091B-45AF-843C-2D57BBD44C19Q35628416-1C54AE49-4BAD-468A-96FB-6596A585BAA0Q35925135-09DDC1A8-4C2B-4551-A985-16A807459E03Q35994680-8B041EAB-D82E-4CC0-BF70-CE1891515DB2Q36120825-AC95F486-5E65-4D40-BB43-FCE3A664D6CBQ36282747-44DA8374-36F4-4E8E-8A3C-1132CF4BCE3AQ36358303-FAA42FBB-0280-4B01-B79C-26F2BE924FA8Q36488894-74CDF558-6629-47AB-9FB7-AFB5B7B84D07Q36520272-C812F4A8-C1A0-440B-945E-A27D0CDEEA5CQ36530658-C0A88902-C1E7-46A5-B182-1AD029E316F5Q36592493-07257265-F35F-4369-BB89-0C6C60D94D7AQ36787259-AE896546-9ED4-4FAC-AA02-F52FCF112063Q36846579-F2F9DA54-AFEE-4538-A64C-39649CEB33D3Q36913771-61C3E020-C419-490D-B557-A47B5E412F7BQ36916482-795211FD-6C6C-42B8-B32B-E1283902772AQ36934782-5A96E7B0-752A-417F-BAA0-F88AA69879D3Q37078475-726E93F5-DD66-4038-8840-1A7FA6B839B7Q37109532-31EA9D44-C923-4038-A919-F11247892C74Q37141642-4A46E680-7033-4230-B5AB-D1DC160459DDQ37160334-98B24AA1-776B-4878-8094-D3B3CF753A39Q37205843-F3D37591-1EF1-4152-B848-12509F6D6B5EQ37233535-E1146847-8520-4964-AF3B-3CF681D60D50
P2860
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Monocyte chemotactic protein-1 ...... te cancer growth and invasion.
@en
type
label
Monocyte chemotactic protein-1 ...... te cancer growth and invasion.
@en
prefLabel
Monocyte chemotactic protein-1 ...... te cancer growth and invasion.
@en
P2093
P356
P1433
P1476
Monocyte chemotactic protein-1 ...... ate cancer growth and invasion
@en
P2093
Diane E George
Guozhi Xiao
Mona F Melhem
P2860
P304
P356
10.1002/PROS.20464
P577
2006-09-01T00:00:00Z